Literature DB >> 10448769

Hazardous and harmful alcohol consumption in primary care.

M C Reid1, D A Fiellin, P G O'Connor.   

Abstract

Increasing emphasis has been placed on the detection and treatment of hazardous and harmful drinking disorders, particularly among patients who are seen in primary care settings. In this review, we summarize the epidemiology and health-related effects of hazardous and harmful drinking and discuss current methods for their detection and treatment. Hazardous drinking is defined as a quantity or pattern of alcohol consumption that places patients at risk for adverse health events, while harmful drinking is defined as alcohol consumption that results in adverse events (e.g., physical or psychological harm). Prevalence estimates range from 4% to 29% for hazardous drinking and from less than 1% to 10% for harmful drinking. Data from several recent large prospective studies suggest that alcohol consumption in quantities consistent with hazardous or harmful drinking may increase risk for adverse health events, such as hemorrhagic stroke and breast cancer. Existing screening instruments, such as the Michigan Alcoholism Screening Test (MAST) or the CAGE questionnaire, while excellent for detecting alcohol abuse or dependence, should not be used alone to screen for hazardous and harmful drinking. The Alcohol Use Disorders Identification Test (AUDIT) is currently the only instrument specifically designed to identify hazardous and harmful drinking. Treatment of these disorders in the form of brief interventions can be successfully accomplished in primary care settings, as demonstrated by a number of well-conducted randomized trials. Given its proven efficacy in the primary care setting, we recommend routine application of this treatment approach.

Entities:  

Mesh:

Year:  1999        PMID: 10448769     DOI: 10.1001/archinte.159.15.1681

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  99 in total

1.  Primary care: is there enough time for prevention?

Authors:  Kimberly S H Yarnall; Kathryn I Pollak; Truls Østbye; Katrina M Krause; J Lloyd Michener
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

2.  Project VALOR: design and methods of a longitudinal registry of post-traumatic stress disorder (PTSD) in combat-exposed veterans in the Afghanistan and Iraqi military theaters of operations.

Authors:  Raymond C Rosen; Brian P Marx; Nancy N Maserejian; Darren W Holowka; Margaret A Gates; Lynn A Sleeper; Jennifer J Vasterling; Han K Kang; Terence M Keane
Journal:  Int J Methods Psychiatr Res       Date:  2011-11-16       Impact factor: 4.035

3.  The Fast Track intervention's impact on behaviors of despair in adolescence and young adulthood.

Authors:  Jennifer W Godwin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

4.  Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.

Authors:  Stephanie S O'Malley; Suchitra Krishnan-Sarin; Sherry A McKee; Robert F Leeman; Ned L Cooney; Boris Meandzija; Ran Wu; Robert W Makuch
Journal:  Int J Neuropsychopharmacol       Date:  2008-09-17       Impact factor: 5.176

5.  Brief Intervention for Emergency Department Patients with Alcohol Misuse: Implications for Current Practice.

Authors:  Robert Woolard; Cheryl Cherpitel; Thompson Kathleen
Journal:  Alcohol Treat Q       Date:  2011-04

6.  Prevalence and factors associated with tuberculosis treatment outcome among hazardous or harmful alcohol users in public primary health care in South Africa.

Authors:  K Peltzer; J S Louw
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

7.  Heavy Alcohol Use Is Associated With Worse Retention in HIV Care.

Authors:  Anne K Monroe; Bryan Lau; Michael J Mugavero; William C Mathews; Kenneth H Mayer; Sonia Napravnik; Heidi E Hutton; Hongseok S Kim; Sarah Jabour; Richard D Moore; Mary E McCaul; Katerina A Christopoulos; Heidi C Crane; Geetanjali Chander
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

Review 8.  Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Authors:  Timothy E Albertson; James Chenoweth; Jonathan Ford; Kelly Owen; Mark E Sutter
Journal:  J Med Toxicol       Date:  2014-12

9.  Alcohol misuse and psychological resilience among U.S. Iraq and Afghanistan era veterans.

Authors:  Kimberly T Green; Jean C Beckham; Nagy Youssef; Eric B Elbogen
Journal:  Addict Behav       Date:  2013-08-31       Impact factor: 3.913

10.  Consumption of alcohol, cigarettes and illegal substances among physicians and medical students in Brandenburg and Saxony (Germany).

Authors:  Karen Voigt; Sabine Twork; Dirk Mittag; Anne Göbel; Roger Voigt; Jörg Klewer; Joachim Kugler; Stefan R Bornstein; Antje Bergmann
Journal:  BMC Health Serv Res       Date:  2009-12-03       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.